These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36371345)

  • 1. EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles.
    Elsherbini N; Kim DH; Payne RJ; Hudson T; Forest VI; Hier MP; Payne AE; Pusztaszeri MP
    J Otolaryngol Head Neck Surg; 2022 Nov; 51(1):43. PubMed ID: 36371345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and phenotypic correlations of EIF1AX mutations in thyroid nodules.
    Karunamurthy A; Panebianco F; J Hsiao S; Vorhauer J; Nikiforova MN; Chiosea S; Nikiforov YE
    Endocr Relat Cancer; 2016 Apr; 23(4):295-301. PubMed ID: 26911375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and Clinical Significance of EIF1AX Mutations and Co-Mutations in Cytologically Indeterminate Thyroid Nodules: A 5-Year Retrospective Analysis.
    Gargano SM; Badjatia N; Nikolaus Y; Peiper SC; Wang ZX
    Acta Med Acad; 2021 Apr; 50(1):4-12. PubMed ID: 34075760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Indicators of
    Bandargal S; Chen T; Pusztaszeri MP; Forest VI; da Silva SD; Payne RJ
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features and outcomes of thyroid nodules with EIF1AX mutations.
    Karslioglu French E; Nikitski AV; Yip L; Nikiforova MN; Nikiforov YE; Carty SE
    Endocr Relat Cancer; 2022 Aug; 29(8):467-473. PubMed ID: 35609001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TERT, HRAS, and EIF1AX Mutations in a Patient with Follicular Adenoma.
    Topf MC; Wang ZX; Tuluc M; Pribitkin EA
    Thyroid; 2018 Jun; 28(6):815-817. PubMed ID: 29669480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient with multiple genetically distinct thyroid nodules including papillary thyroid carcinoma harboring novel YWHAG-BRAF fusion.
    Lin R; Wang ZX; Cottrill E; Badjatia N; Gargano SM
    Cancer Genet; 2022 Aug; 266-267():51-56. PubMed ID: 35780657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
    Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
    Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.
    Macerola E; Rago T; Proietti A; Basolo F; Vitti P
    J Endocrinol Invest; 2019 Feb; 42(2):157-166. PubMed ID: 29704233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EIF1AX mutation in thyroid nodules: a histopathologic analysis of 56 cases in the context of institutional practices.
    Abi-Raad R; Xu B; Gilani S; Ghossein RA; Prasad ML
    Virchows Arch; 2024 Nov; 485(5):859-867. PubMed ID: 39225726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
    Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
    Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
    Alzahrani AS; Murugan AK; Qasem E; Alswailem MM; AlGhamdi B; Moria Y; Al-Hindi H
    Endocrine; 2019 Jan; 63(1):94-100. PubMed ID: 30269267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indeterminate Thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
    Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
    Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Genetics Augment Cytopathologic Evaluation and Surgical Planning of Pediatric Thyroid Nodules.
    Spaulding SL; Maayah M; Dinauer CA; Prasad M; Darbinyan A; Morotti R; Christison-Lagay ER
    J Pediatr Surg; 2024 May; 59(5):975-980. PubMed ID: 38246817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of EIF1AX in thyroid cancer tumourigenesis and progression.
    Simões-Pereira J; Moura MM; Marques IJ; Rito M; Cabrera RA; Leite V; Cavaco BM
    J Endocrinol Invest; 2019 Mar; 42(3):313-318. PubMed ID: 29968046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Bethesda category and molecular mutation in patients undergoing thyroidectomy.
    Mascarella MA; Peeva M; Forest VI; Pusztaszeri MP; Avior G; Tamilia M; Mlynarek AM; Hier MP; Payne RJ
    Clin Otolaryngol; 2022 Jan; 47(1):75-80. PubMed ID: 34510770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of driver mutations in plasma cell-free nucleic acids in differentiated thyroid neoplasm.
    Dutta S; Tarafdar S; Mukhopadhyay P; Bhattacharyya NP; Ghosh S
    Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36744987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
    Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
    Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.
    Radkay LA; Chiosea SI; Seethala RR; Hodak SP; LeBeau SO; Yip L; McCoy KL; Carty SE; Schoedel KE; Nikiforova MN; Nikiforov YE; Ohori NP
    Cancer Cytopathol; 2014 Dec; 122(12):873-82. PubMed ID: 25132659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.